St. Kitts & Nevis Business Watch
SEE OTHER BRANDS

The latest business and economy news from Saint Kitts and Nevis

St. Kitts & Nevis Business Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Kitts & Nevis Business Watch.

Press releases published on August 1, 2025

Opendoor Regains Compliance with Nasdaq Minimum Bid Price Requirement and Cancels Special Meeting of Stockholders
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
Uniti Completes Merger with Windstream
Enovix Shareholder Reminder: Early Warrant Expiration Price Condition
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
ThreeD Capital Inc. Completes Private Placement Financing
Guggenheim Investments Announces August 2025 Closed-End Fund Distributions
Spyre Therapeutics Announces Grants of Inducement Awards
Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces its Net Asset Value and Asset Coverage Ratios as of July 31, 2025
Johnson Fistel Continues Investigation on Behalf of Proficient Auto Logistics, Inc. (PAL) Shareholders
“Bogotá concentra el 60% de la inversión extranjera en tecnología que llega a Colombia”
“Bogotá Accounts for 60% of Foreign Investment in Technology Entering Colombia”
LMT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Lockheed Martin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Toll Brothers to Webcast Its Third Quarter 2025 Earnings Conference Call Live on August 20, 2025 at 8:30 a.m. (ET)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Sirona Biochem Update to Shareholders on Financial Status and Operations
WEBUY GLOBAL LTD Announces Closing of Follow-on Offering
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions